StockpollyBeta
Get App
Popularity #432
REPL · NASDAQ · Biotechnology

Replimune Group (REPL)

Develops RPx oncolytic immunotherapies for melanoma and other solid tumors.

$13.47
After hours0.00 (0.00%)
At close$13.47(+4.66%)

  1. Portnoy Law Firm Announces Class Action on Behalf of Replimune Group, Inc. Investors

    GlobeNewsWire

  2. REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

    GlobeNewsWire

  3. REPL Stockholders with Significant Losses Should Contact Robbins LLP Before the Pending October 5, 2026 Lead Plaintiff Deadline for Information About Recovering Their Losses

    GuruFocus

  4. REPL Stockholders with Significant Losses Should Contact Robbins LLP Before the Pending October 5, 2026 Lead Plaintiff Deadline for Information About Recovering Their Losses

    PRNewsWire

  5. Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

    GlobeNewsWire

  6. REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt

    PRNewsWire

  7. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL

    PRNewsWire

  8. DEADLINE ALERT for REPL, DVLT, and UWMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

    Globe News Wire

  9. Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. Lawsuit - REPL

    PRNewsWire

  10. Squarepoint Ops LLC Takes Position in Replimune Group, Inc. $REPL

    Defense World

  11. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

    GlobeNewsWire

  12. Portnoy Law Firm Announces Class Action on Behalf of Replimune Group, Inc. Investors

    GlobeNewsWire

  13. SueWallSt Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026 - REPL

    GlobeNewsWire

  14. Replimune Group, Inc. (REPL) Shareholder/Analyst Call Prepared Remarks Transcript

    Seeking Alpha

  15. REPL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Replimune Group, Inc. Securities Lawsuit - Contact Levi & Korsinsky

    GlobeNewsWire

  16. Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

    GlobeNewsWire

  17. REPL Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Replimune Group, Inc.

    GlobeNewsWire

  18. Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

    Newsfile Corp

  19. Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Replimune Group Inc. and Encourages Investors to Contact the Firm

    GlobeNewsWire

  20. REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class Action - Contact Levi & Korsinsky

    GuruFocus